Top Story
Sanofi to invest $6B in vaccine production
The growing wealth seen in developing nations is spurring a big increase in the worldwide demand for vaccines, and Sanofi-Aventis says it will invest more than $6 billion over the next eight years in order to meet the projected demand. Read more...
Report
Gates and GAVI gear up global vaccine initiative
The Global Alliance for Vaccines and Immunization, which is backed by a host of international health groups and the Gates Foundation, is preparing a huge new initiative to vaccinate millions of children in developing nations. Report
From the Network
Press Releases
- FDA Extends Review Period for Daiichi Sankyo, Lilly Investigative Antiplatelet Drug, Prasugrel
- Commercial Launch of Lexiscan Injection Triggers $10 Million Milestone Payment from TPG-Axon Capital to CV Therapeutics
- Boehringer Ingelheim And GENEART Collaborate On Offering Design And Production Services For DNA Therapeutics And Vaccines
- Genzyme and Isis complete licensing of mipomersen
- EyeCyte, Inc. Secures Series A Funding from Pfizer
Latest Comments
Editors
About FierceVaccines
FierceVaccines gives industry insiders the latest vaccine industry news and developments. Our FREE weekly email newsletter covers the people, trends, and research projects shaping the vaccine market.
© FierceMarkets, Inc.
® All rights reserved
1319 F St NW, 6th Floor
Washington, D.C. 20004
+1.202.628.8778
www.fiercemarkets.com
Latest News
Cervical cancer vaccine bound for clinic; Businesses warned to prepare for vax campaigns;
Vaccine Research VGX Pharmaceuticals says that the FDA has accepted its IND for an experimental DNA vaccine for cervical cancer. VGX-3100 will go into Phase I in the third quarter. Read more...
Pediatricians get tough with vaccine doubters
The American Academy of Pediatrics say that more and more parents are resisting the vaccinations that are recommended for their children, and they're mounting a promotional campaign in an attempt to Read more...
Combo vaccines endorsed by federal advisory panel
In a move that should make it easier for millions of children in the U.S. to get their recommended vaccinations, a federal vaccine advisory panel has endorsed two new combination vaccinations. Read more...
Glaxo ready to wait for late-stage Cervarix data
GlaxoSmithKline now says it will wait for the completion of a late-stage trial of its cervical cancer vaccine Cervarix before answering the FDA's questions about the therapy. That will push back any Read more...
Poland investigates deaths of homeless in vaccine trial
Polish officials are investigating the deaths of a number of homeless people who were recruited to take part in a clinical trial of a new avian flu vaccine trial. According to some of the officials, Read more...
Wall Street shrugs off FDA’s Gardasil rejection
Many Wall Street analysts greeted the FDA's decision to reject Merck's bid to expand the use of Gardasil to 27 to 45-year-old women with a yawn. For many on Wall Street, the key market for the Read more...
Merck’s rotavirus vaccine makes big impact
A new report by the CDC concludes that Merck's new rotavirus vaccine has made a major impact on the disease in the last two years. RotaTeq, designed to prevent diarrhea and vomiting in children, has Read more...
$200M vaccine plant for China; Researchers advance bowel cancer vaccine;
Vaccine Market Canada's Microbix Biosystems is plotting a $200 million flu vaccine plant in Hunan province. The cooperative deal puts Microbix in partnership with the Hunan government, which will put Read more...
Paid Research Reports
- Drug Repositioning Strategies - Serendipity by design
- eHealthInsight Series: Online Patient Recruitment Strategies - Optimizing the clinical trial process
- Pricing & Reimbursement - Seven Major Markets Update
- Innovative Clinical Trial Design and Management: Trends, success stories and impact upon R&D budgets
- The Emerging Role of Postmarketing Clinical Research: Regulatory issues, strategic drivers and overall trends